Navigation Links
Eli Lilly and Company Announces New Drug Discovery Initiative
Date:6/15/2009

Goal is to foster open collaboration between Lilly and global laboratory researchers

INDIANAPOLIS, June 15 /PRNewswire-FirstCall/ -- Alzheimer's disease. Cancer. Diabetes. Osteoporosis.

These are the diseases for which Eli Lilly and Company will be engaging researchers from around the world in a new and unique drug discovery initiative.

The initiative, called the Lilly Phenotypic Drug Discovery Initiative, or PD2 (pronounced PD-squared)*, uses Lilly-developed disease-state assays and a secure web portal to evaluate the therapeutic potential of compounds synthesized in university and biotechnology laboratories. Findings from this initiative could ultimately form the basis for collaboration or licensing agreements between Lilly and external institutions.

"Each year, researchers throughout the world design and synthesize compounds in university and biotechnology laboratories that are never fully evaluated as potential drug candidates," said Alan D. Palkowitz, Ph.D., vice president of discovery chemistry research and technologies at Lilly. "There's an untapped source of ideas and compounds in the greater scientific community that could ultimately impact patients' lives following further evaluation and development."

Collaborations between Lilly and external researchers are not new; however, the PD2 initiative is designed to provide a more convenient point of entry for global external researchers into Lilly's drug discovery and development process. By doing so, PD2 allows for the establishment of productive relationships with institutions and organizations that may not previously have worked with Lilly.

"Increasingly, innovation depends on a broad network of relationships outside our walls," said Palkowitz, adding that PD2 is yet another example of Lilly's evolving transformation from a Fully Integrated Pharmaceutical Company, or FIPCO, to a Fully In
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case
2. ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
3. Bart Peterson to Join Lilly Leadership Team
4. Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
5. Amgens Denosumab and Eli Lillys Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018
6. Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
7. Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management
8. Lilly to Celebrate Second Annual Global Day of Service May 20
9. Lilly Chairman & CEO Lechleiter Says Innovation Is Vital-But-Missing Plank in Health Reform Debate
10. Lilly USA, LLC and Vision Racing Encourage Fans to get on Track With Their Health
11. WuXi AppTec Receives 2009 Lilly Global Supplier Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... measure damaging "brain tsunamis" in injured patients without ... to reality, thanks to pioneering research at the ... research team, led by Jed Hartings, PhD, research ... the UC College of Medicine, has shown that ... brain like tsunami wavescan be measured by the ...
(Date:9/30/2014)... lung cancer, breast cancer is the leading cause of ... Society. That,s why so many medical professionals encourage women ... at best: only a minority of suspicious mammograms actually ... lots of needless worry for women and their familiesnot ... tests, including ultrasounds and biopsies. , Recently, a ...
(Date:9/30/2014)... Legislation passed in 2003 to slow the spiraling ... to treat Medicare patients has had no meaningful impact ... researchers in the Journal of Clinical Oncology ... outpatient chemotherapy to treat colorectal and lung cancers, and ... prescribe those drugs following the implementation of the recent ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Integrated ... wellness, is opening another new medical specialty practice through ... IMA Cardiology will be located within the company’s ... Abbud and Dr. Isaac Tawfik of American Heart Center, ... The new practice will offer Integrated Medicine Alliance patients ...
(Date:9/30/2014)... 2014(BRONX, NY)Medications are the leading cause of allergy-related sudden ... death certificates from 1999 to 2010, conducted by researchers ... Albert Einstein College of Medicine of Yeshiva University . ... of Allergy and Clinical Immunology , also found that ... high among older people and African-Americans and that such ...
Breaking Medicine News(10 mins):Health News:Researchers show EEG's potential to reveal depolarizations following TBI 2Health News:Researchers show EEG's potential to reveal depolarizations following TBI 3Health News:'Virtual breast' could improve cancer detection 2Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2
... The LFA asks people to join them and show ... FDA-approved medication specifically for lupus , , WASHINGTON, ... Administration (FDA) approved a medication to treat lupus -- when Dwight D. ... effective medications, the Lupus Foundation of America, Inc. (LFA) today launched its ...
... , FLINT, Mich., Sept. 22 Cancer patients residing ... of the most advanced forms of treatment available with a new ... Texas-based health care technology company. , , ... , combines the most advanced treatment capabilities in ...
... , NEW YORK, Sept. 22 Assurant, Inc. ... and insurance-related products and services, will release 2009 third quarter financial results ... will be available on Assurant,s Web site at www.assurant.com ... third quarter conference call at 9:00 a.m. ET on Thursday, Oct. 29, ...
... 22 MedCath Corporation (Nasdaq: MDTH ), a ... diagnosis and treatment of cardiovascular disease, today announced that Art ... Officer effectively immediately. , , Parker ... the company has expanded both the size of its facilities ...
... DENVER, Sept. 22 Anthem Blue Cross and ... has been awarded an Accreditation status of Excellent from the ... that assesses and reports on the quality of the nation,s ... possible level -- is based on a voluntary review of ...
... , , MANHATTAN, Kan., ... Michael Cates, DVM, raised awareness about the One Health Commission at ... Dr. Cates, director of the university,s Master of Public Health Program, ... are very much a "one health" concern. , , ...
Cached Medicine News:Health News:The Lupus Foundation of America, Inc. Asks Supporters to Band Together for Lupus(SM) 2Health News:McLaren Health Care Forming Partnership With ProTom International to Build First Proton Beam Therapy Center In Michigan 2Health News:McLaren Health Care Forming Partnership With ProTom International to Build First Proton Beam Therapy Center In Michigan 3Health News:McLaren Health Care Forming Partnership With ProTom International to Build First Proton Beam Therapy Center In Michigan 4Health News:Assurant to Announce 2009 Third Quarter Results Oct. 28, 2009 and Host Webcast Conference Call Oct. 29 2Health News:MedCath Names Art Parker Executive Vice President and Chief Financial Officer 2Health News:Anthem Blue Cross and Blue Shield Awarded NCQA's Accreditation Status of 'Excellent' 2Health News:One Health Commission Teaming Up With World Rabies Day to Spread the 'One Health' Message 2
(Date:9/30/2014)... Sept. 30, 2014  Georgia-Pacific Professional is a ... tissue for a wide range of away from ... product lines in healthcare, including hospitals, long-term care ... is introducing its healthcare products and solutions to ... the importance of infection control in the dental ...
(Date:9/30/2014)... 30, 2014 The report based ... Size, Share, Growth and Forecast, 2007 - 2017," elaborated ... USD 20.8 billion in 2012 and is further expected ... a CAGR of 7.3% from 2012 to 2017. ... health purposes, especially to prevent chronic diseases that may ...
(Date:9/30/2014)... BURLINGTON, Mass. , Sept. 30, 2014 /PRNewswire/ ... of U.S. patient-level claims data, anemic chronic kidney ... with their erythropoiesis-stimulating agent (ESA) medication. In addition, ... Janssen,s Procrit. Other key findings ... in Nephrology: An Analysis of Erythropoiesis Stimulating Agents ...
Breaking Medicine Technology:Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3
... (NYSE Amex: NBS ) ("NeoStem" or the ... cell based therapeutics development, today announced two appointments to ... Greenacre, an experienced business leader in the biopharmaceutical industry ... and joins as an additional independent director, and Dr. ...
... YORK, Dec. 8, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p090656/Global-Gamma/Scintillation-Cameras-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Camera This report ... in US$ Thousand by the following Product ...
Cached Medicine Technology:NeoStem Appoints a Biopharmaceutical Business Leader and a Cellular Therapy Expert to its Board of Directors 2NeoStem Appoints a Biopharmaceutical Business Leader and a Cellular Therapy Expert to its Board of Directors 3NeoStem Appoints a Biopharmaceutical Business Leader and a Cellular Therapy Expert to its Board of Directors 4Global Gamma/Scintillation Cameras Industry 2Global Gamma/Scintillation Cameras Industry 3Global Gamma/Scintillation Cameras Industry 4Global Gamma/Scintillation Cameras Industry 5Global Gamma/Scintillation Cameras Industry 6Global Gamma/Scintillation Cameras Industry 7Global Gamma/Scintillation Cameras Industry 8Global Gamma/Scintillation Cameras Industry 9Global Gamma/Scintillation Cameras Industry 10Global Gamma/Scintillation Cameras Industry 11Global Gamma/Scintillation Cameras Industry 12Global Gamma/Scintillation Cameras Industry 13Global Gamma/Scintillation Cameras Industry 14Global Gamma/Scintillation Cameras Industry 15Global Gamma/Scintillation Cameras Industry 16Global Gamma/Scintillation Cameras Industry 17Global Gamma/Scintillation Cameras Industry 18Global Gamma/Scintillation Cameras Industry 19
... is a suture option for ... diameter looped FiberWire products allow ... extensor tendon repairs while reducing ... passes. FiberLoop is available with ...
... study remains the mainstay in a urologic workup. ... patient needs for an accurate, easy-to-use in-office uroflow ... onset of urine flow and automatically ends when ... urine flow. There is no need to have ...
UroPass Open Tip Ureteral Stents perfect over-the-wire placement with a combination of flexibility and rigidity for comfort and control. When it comes to stent designs, UroPass is a proven leader....
... Ureteral Stents feature teardrop shaped kidney curls ... hydrophilic coating for ease of placement, and ... the trigone. The Multi-Flex advanced design has ... segment provides pushability for placement, and strength ...
Medicine Products: